Fact-checking during a pandemic: A response to Biocon and the Telegraph
Strategic Management Analysis of Biocon India Group Limited - CIRCLE OF BUSINESS Strategic Management Analysis of Biocon India Group Limited
Biocon, Quark to start clinical tests for eye disorder drug | Mint
Biocon Ltd Clinical Trials - GlobalData
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars | British Journal of Cancer
Biocon - Wikipedia
Biocon Business
Biocon forced to move clinical trials out of India | Business Standard News
Biocon KGI Certificate Program in Clinical Development - Biocon Academy
Indian officials arrest 5 in bribery case tied to Biocon
Phase 3 clinical trial waived off for Biocon's COVID-19 drug
Biocon's Itolizumab Drug For Emergency Use on COVID-19 Patients Gets Approval After Clinical Trial on 30 Patients Across Only 4 Hospitals | 📰 LatestLY
List of Clinically Tested Oral Insulin Formulations. | Download Table
CBI chargesheet in Biocon case raises questions about how India manages drug trials
Group-07 CASE-1 Analysis - CASE ANALYSIS BIOCON: LAUNCHING A NEW CANCER DRUG IN INDIA Introduction - StuDocu
What is the controversy regarding Biocon's COVID-19 drug Itolizumab? - Quora
सिद्धार्थ on Twitter: "Brief summary here: 👉 Biocon Biologics had submitted result to https://t.co/pXvPY9Oaef @NIH on Aug 02, 2020 BUT results were returned after quality control review on Aug 10, 2020. On
biocon: Biocon Biologics says clinical study for drug Itolizumab initiated in India after approval from DCGI - The Economic Times
Infographic: Biocon opens this year with a stellar performance reporting 71% growth in profits | AlphaStreet
Biocon subsidiary caught offering bribe to waive off trial of new drug - The Hindu
Biocon founder Kiran Mazumdar Shaw says India's Covid-19 vaccine will enter clinical trials in 9 months
COVID-19: Hundreds Of Clinical Trials Under Way In India, Many Lack Rigour, Say Experts
